8-K Announcements
6Material company update
Jul 27, 2026·SEC
Material company update
Jul 10, 2026·SEC
Material company update
Jun 17, 2026·SEC
GeoVax Labs faces a precarious outlook as its reliance on volatile, non-recurring grant revenue has led to a complete cessation of income in recent quarters. The company's heavy fixed-cost structure, characterized by quarterly R&D expenditures often exceeding ...
Price trend, volume and key moving averages
Trailing total returns as of 9/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Jul 27, 2026 | -$0.97+55.1% vs -$2.16 | — vs — |
Q2 2026 May 14, 2026 | -$2.62-63.7% vs -$1.60 | — vs — |
Q2 2026 Apr 2, 2026 | -$2.29+51.3% vs -$4.71 | — vs $1M |
Q4 2025 Nov 13, 2025 | -$7.75-29.2% vs -$6.00 | — vs — |
Benchmark GOVX against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for GeoVax Labs, Inc. (GOVX)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.37 | $354.63K | -0.02 | -37.06% | -862.34% | -483.79% | — | |
| $10.83 | $1.78B | 4.26 | 64.69% | -59.87% | — | — | |
| $10.64 | $4.75B | -9.76 | 60.6% | -89.09% | -40.51% | — | |
| $15.50 | $1.82B | 77.50 | 19.36% | -13.13% | -8.13% | — | |
| $3.26 | $233.82M | 9.88 | -31.8% | -5.14% | -1.53% | — | |
| $8.70 | $362.29M | -2558.82 | 10.37% | 69.76% | — | — |
GeoVax Labs, Inc. (GOVX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
GeoVax Labs, Inc. (GOVX) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jul 27, 2026·SEC
Jul 10, 2026·SEC
Jun 17, 2026·SEC
Get notified when GOVX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
GeoVax Labs, Inc. (GOVX) stock FAQ — growth, dividends, profitability & financials explained
GeoVax Labs, Inc. (GOVX) reported $2.5M in revenue for fiscal year 2025. This represents a 2550% increase from $0.1M in 1996.
GeoVax Labs, Inc. (GOVX) saw revenue decline by 37.1% over the past year.
GeoVax Labs, Inc. (GOVX) reported a net loss of $20.4M for fiscal year 2025.
GeoVax Labs, Inc. (GOVX) has a return on equity (ROE) of -483.8%. Negative ROE indicates the company is unprofitable.
GeoVax Labs, Inc. (GOVX) had negative free cash flow of $18.4M in fiscal year 2025, likely due to heavy capital investments.